Suzhou-based Kolo Medical Inc., a leader in next-generation semiconductor ultrasound CMUT (Capacitive Micromachined Ultrasonic Transducer) chip technology, has raised nearly RMB 100 million (USD 14.8 million) in a Series B2 financing round. The round was led by Qianrong Investment and included participation from Walden International.
Funding Use
Proceeds from the funding will support the global launch of Kolo’s in-house developed high-frequency ultrasound imaging system and the development of next-generation CMUT chips and novel ultrasound imaging products.
Company Profile
Kolo, the world’s only company in the industry without the need for third-party licensing, offers Paragon XHD, its first-generation medical ultrasound product used in dermatology, medical aesthetics, and plastic surgery. The second-generation product features an array probe above 70MHz, with image resolution improved to 30 microns, providing high value in ophthalmic clinical diagnosis, small animal clinical experiments, and biomedical scientific research.-Fineline Info & Tech
